✦ LIBER ✦
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
✍ Scribed by Park, K. H.; Sohn, J. H.; Lee, S.; Park, J. H.; Kang, S. Y.; Kim, H. Y.; Park, I. H.; Park, Y. H.; Im, Y. H.; Lee, H. J.; Hong, D. S.; Park, S.; Shin, S. H.; Kwon, H. C.; Seo, J. H.
- Book ID
- 125358922
- Publisher
- Springer US
- Year
- 2013
- Tongue
- English
- Weight
- 162 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.